Clinical Trial Update: COVID-19 Antibody Responses in Cystic Fibrosis

View source ↗

Summary

The completed study reports on SARS-CoV-2 antibody responses in people with cystic fibrosis, outlining observed antibody kinetics and potential implications for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Cystic Fibrosis, Covid19 | Status: COMPLETED